FN2 Earnings Intelligence

American Healthcare REIT, Inc. earnings overview

Latest American Healthcare REIT, Inc. (AHR) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.

AHR FY2026 Q2 · Calendar Q3 2026

American Healthcare REIT, Inc.

AHR's Q2 call strengthened the case for durable senior-housing growth: same-store NOI growth remained double digit, guidance rose, and the acquisition platform expanded. The counterweight is execution—sustaining cost improvements, integrating assets, funding growth, and maintaining deal quality.

EPS surprise+16.6%
Market move+3.7%
AHR FY2026 Q1 · Calendar Q2 2026

American Healthcare REIT, Inc.

The call supports a constructive operating thesis: senior-housing demand, quality-mix improvement and disciplined acquisitions are reinforcing growth. The counterpoint is that funding needs, regulation and the durability of margin gains remain important tests.

EPS surprise-19.2%
Market move+4.3%
AHR FY2025 Q3 · Calendar Q4 2025

American Healthcare REIT, Inc.

The supplied analysis supports a constructive operating thesis for AHR: resilient senior-housing demand, occupancy above 90%, higher guidance, acquisitions, and deleveraging provide evidence of growth. The thesis remains conditional on executing the acquisition and development pipeline without losing pricing power or facing weaker reimbursement trends.

EPS surprise-21.4%
Market move+3.1%
AHR FY2025 Q2 · Calendar Q3 2025

American Healthcare REIT, Inc.

The current analysis supports a constructive operating thesis: senior housing momentum, improving occupancy, revenue-management capabilities, and acquisitions are reinforcing growth. The thesis remains dependent on sustaining pricing and occupancy gains while managing outpatient exposure and financing costs.

EPS surprise-85.0%
Market move+1.6%
AHR FY2024 Q4 · Calendar Q1 2025

American Healthcare REIT, Inc.

The supplied analysis provides evidence for a cautiously constructive operating thesis: strong 2024 same-store NOI growth, occupancy and revenue-per-occupied-room momentum, development plans and acquisition capacity support continued growth. The counterweight is that 2025 guidance is more measured, so execution, lease renewals, reimbursement policy and financing costs should determine whether resilience persists.

EPS surprise—
Market move-1.3%

Get the AHR recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.